QID 377904

Date Published: 2023-01-18

QID 377904: Oracle Java Standard Edition (SE) Critical Patch Update - January 2023 (CPUJAN2023)

Oracle Java Runtime Environment (JRE) is a platform that supports the execution of programs that are developed using the Java programming language. The JRE platform also supports Java Applets, which can be loaded from Web pages.

Oracle Java JRE and JDK contain multiple remotely exploitable vulnerabilities that affect various components.

Affected Versions:
Oracle Java SE prior to : 8u361, 8u361-perf, 11.0.18, 17.0.6 and 19.0.2

QID Detection Logic (Authenticated):
Operating System: Windows
This QID checks for the file or product version of jvm.dll or wsdetect.dll or verify.dll.

QID Detection Logic (Authenticated):
Operating System: Linux
This QID checks product version from the java binary.

Successful exploitation could allow an attacker to affect the confidentiality, integrity and availability of data on the target system.

CVSS V3 rated as Medium - 5.3 severity.

CVSS V2 rated as High - 6.4 severity.

Solution

The vendor has released updates to resolve these issues.

Customers are advised to refer to vendor advisory Oracle Critical Patch Update Advisory - January 2023

Vendor References

Oracle Critical Patch Update Advisory - January 2023 - www.oracle.com/security-alerts/cpujan2023.html

CVEs related to QID 377904

CVE-2023-21835 | CVE-2023-21830 | CVE-2023-21843 |

Software Advisories

Advisory ID	Software	Component	Link
Oracle Critical Patch Update Advisory - Jan 2023			www.oracle.com/security-alerts/cpujan2023.html

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].